Search

everythinglearnresearchcommunity

for

Search:↓

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Juniperus plants contain compounds with potential for developing various medical treatments.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

COVID-19 may harm male fertility and damage the reproductive system.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Minoxidil works well as a high permeability reference drug for biopharmaceutics classification.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Using existing drugs for new treatments is cost-effective and safer.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

A baby girl's hair turned straight on one side due to a neck tumor and surgery, but it returned to curly as she recovered.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.